WHO’s IARC: Cancer Diagnoses/Deaths to Double by 2030

Publication
Article
OncologyONCOLOGY Vol 24 No 7
Volume 24
Issue 7

Officials at the International Agency for Research on Cancer in Lyon, France, part of the World Health Organization, have announced findings from GLOBOCAN 2008, an online resource that provides worldwide estimates of numbers of new cases, and deaths from, cancer for 2008.

Officials at the International Agency for Research on Cancer in Lyon, France, part of the World Health Organization, have announced findings from GLOBOCAN 2008, an online resource that provides worldwide estimates of numbers of new cases, and deaths from, cancer for 2008. Based on the data, the IARC estimates that by 2030, nearly 21.4 million new cancer cases will be diagnosed worldwide-mostly in developing countries-and there will be more than 13.2 million deaths, compared with 12.7 million new cases and 7.6 million deaths in 2008.

Articles in this issue
Primary Cutaneous and Systemic Anaplastic Large Cell Lymphoma
Exploring the Interface Between Cancer and Psychiatry
Ipilimumab Ups Survival in Metastatic Melanoma Phase III Trial
Ovarian Cancer Screening Tool, ROCA, Yields Promising Results
Phase III RTOG Data Confirm Survival Advantage for Patients With HPV+ Oropharyngeal Ca
Understanding Evaluation and Management of Primary Cutaneous and Systemic ALCL
Improved Understanding of Peripheral T-cell Lymphomas
Interpretation of Genome-Wide Association Study Results
Genome-Wide Association Studies of Cancer: Principles and Potential Utility
Optimizing Treatment Benefit in Older Breast Cancer Patients
Adjuvant Chemotherapy of Breast Cancer in the Older Patient
Vitamin E
Vitamin E
Melanoma’s Radioresistant Reputation Challenged
Melanoma Metastatic to Multiple Visceral Organs: Further Considerations
WHO’s IARC: Cancer Diagnoses/Deaths to Double by 2030
Related Videos
Related Content
69 The Importance of Tri-Modality Therapy for De Novo Stage IV Invasive Lobular Carcinoma (ILC) Presenting With Bone-Only Metastases

69 The Importance of Tri-Modality Therapy for De Novo Stage IV Invasive Lobular Carcinoma (ILC) Presenting With Bone-Only Metastases

April 21st 2024
Article
Stem Cell Transplant Approaches for Patients With Blood Cancers

Stem Cell Transplant Approaches for Patients With Blood Cancers

March 13th 2019
Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma

Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma

April 19th 2024
Article

Omid Hamid, MD, gives his perspective on the use of tumor-infiltrating lymphocyte therapy for patients with melanoma.

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

March 13th 2019
Podcast

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.

The Impact of CAR T-Cell Therapy on Hematological Malignancies

The Impact of CAR T-Cell Therapy on Hematological Malignancies

March 11th 2024
Article

Jae Park, MD, discussed the use of CAR T-cell therapy across the hematologic malignancies space.

HER3-DXd May Lead to an Additional Treatment Option in EGFR+ NSCLC

HER3-DXd May Lead to an Additional Treatment Option in EGFR+ NSCLC

March 10th 2024
Article

Helena A. Yu, MD, and Sandip P. Patel, MD, reviewed the use of patritumab deruxtecan, which was assessed in the phase 2 HERTHENA-Lung01 trial.